Assessment of Vaccination Coverage Required for Covid-19 Incidence Control

A. Gerasimov
{"title":"Assessment of Vaccination Coverage Required for Covid-19 Incidence Control","authors":"A. Gerasimov","doi":"10.31031/cjmi.2020.03.000590","DOIUrl":null,"url":null,"abstract":"For the vast majority of countries, effective control over COVID-19 incidence without mass vaccination is not possible. More than 100 research centers are successfully developing and testing the vaccine; mass vaccination can be expected from early 2021. The article describes how to evaluate the activity of the transmission mechanism and the necessary level of collective immune status, created by vaccination, taking into account the “seasonal factor” and collective immunity received from diseases of coronavirus infection. In particular, for Moscow the minimum proportion of the population that needs to become immune is currently 48.7%, if inoculated without serological control, and 36.5% if inoculation receive those who have no immunity.","PeriodicalId":406162,"journal":{"name":"Cohesive Journal of Microbiology & Infectious Disease","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cohesive Journal of Microbiology & Infectious Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31031/cjmi.2020.03.000590","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

For the vast majority of countries, effective control over COVID-19 incidence without mass vaccination is not possible. More than 100 research centers are successfully developing and testing the vaccine; mass vaccination can be expected from early 2021. The article describes how to evaluate the activity of the transmission mechanism and the necessary level of collective immune status, created by vaccination, taking into account the “seasonal factor” and collective immunity received from diseases of coronavirus infection. In particular, for Moscow the minimum proportion of the population that needs to become immune is currently 48.7%, if inoculated without serological control, and 36.5% if inoculation receive those who have no immunity.
Covid-19发病率控制所需疫苗接种覆盖率评估
对于绝大多数国家来说,不进行大规模疫苗接种就不可能有效控制COVID-19的发病率。100多个研究中心正在成功地开发和测试这种疫苗;预计从2021年初开始将进行大规模疫苗接种。本文描述了如何评估传播机制的活性和疫苗接种所产生的必要的集体免疫状态水平,同时考虑到“季节性因素”和冠状病毒感染疾病所获得的集体免疫。特别是在莫斯科,如果没有血清学控制接种,目前需要免疫的人口比例最低为48.7%,如果接种接种则为36.5%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信